JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB245774

Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free

Be the first to review this product! Submit a review

|

(2 Publications)

Rabbit Recombinant Monoclonal Cytochrome P450 3A4/CYP3A4 antibody. Carrier free. Suitable for IP, WB, IHC-P and reacts with Human, Transfected cell line - Human samples. Cited in 2 publications.

View Alternative Names

CYP3A3, CYP3A4, Cytochrome P450 3A4, Albendazole monooxygenase (sulfoxide-forming), Albendazole sulfoxidase, CYPIIIA3, CYPIIIA4, Cholesterol 25-hydroxylase, Cytochrome P450 3A3, Cytochrome P450 HLp, Cytochrome P450 NF-25, Cytochrome P450-PCN1, Nifedipine oxidase, Quinine 3-monooxygenase

6 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human liver tissue sections labeling Cytochrome P450 3A4/CYP3A4 with purified ab124921 at 1/400 dilution (0.35 μg/ml). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

ab124921 (unpurified), at a 1/100 dilution, staining Cytochrome P450 3A4/CYP3A4 in paraffin embedded Human liver tissue by Immunohistochemistry.

This data was developed using the same antibody clone in a different buffer formulation containing Tris glycine, glycerol and sodium azide (ab124921).

Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • IP

Unknown

Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

ab124921 (purified) at 1/20 dilution (1ug) immunoprecipitating Cytochrome P450 3A4/CYP3A4 in Human liver lysates.
Lane 1 : Human liver lysates 10ug
Lane 2 (+) : ab124921 & Human liver lysates
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab124921 in Human liver lysates
For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).

All lanes:

Immunoprecipitation - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>)

Predicted band size: 57 kDa

false

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • WB

Unknown

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

HepG2 cells were incubated at 37°C for 48h with vehicle control (0 μM) and different concentrations of nicardipine hydrochloride (ab120531) in DMSO. Increased expression of Cytochrome P450 3A4/CYP3A4 (ab124921) correlates with an increase in nicardipine hydrochloride concentration, as described in literature. Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab124921 at 1/10000 dilution and ab9484 at 1 μg /ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution. This data was developed using the same antibody clone in a different buffer formulation containing Tris glycine, glycerol and sodium azide (ab124921).

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>)

Predicted band size: 57 kDa

true

Exposure time: 20min

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • WB

Supplier Data

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab124921).

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

ab205606 was used as a tag loading control.

The detection of CYP3A4 recombinant protein or over -expressed protein with a C - terminal tag yielded a negative result because the immunogen of this product is located at the C - terminal of CYP3A4.

All lanes:

Western blot - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] (<a href='/en-us/products/primary-antibodies/cytochrome-p450-3a4-cyp3a4-antibody-epr6202-ab124921'>ab124921</a>) at 1/1000 dilution

Lane 1:

293T cells transfected with an empty vector containing a Flag tag whole cell lysate at 20 µg

Lane 2:

293T cells transfected with a human CYP3A4 expression vector containing a N-terminal Flag tag whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 50 kDa

false

Exposure time: 1s

OI-RD Scanning - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)
  • OI-RD Scanning

Supplier Data

OI-RD Scanning - Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202] - BSA and Azide free (AB245774)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen) of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol and sodium azide (ab124921).

  • Unconjugated

    Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]

  • Biotin

    Biotin Anti-Cytochrome P450 3A4/CYP3A4 antibody [EPR6202]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6202

Isotype

IgG

Carrier free

Yes

Reacts with

Human

Applications

WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

Cross-reactivity with other CYP3A family: This antibody has high posibility of reacting with CYP3A7 based on our internal test.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p>The detection of CYP3A4 recombinant protein or over -expressed protein with a C - terminal tag yielded a negative result because the immunogen of this product is located at the C - terminal of CYP3A4.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Transfected cell line - Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>The detection of CYP3A4 recombinant protein or over -expressed protein with a C - terminal tag yielded a negative result because the immunogen of this product is located at the C - terminal of CYP3A4.</p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

ab245774 is the carrier-free version of ab124921.

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.

Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.

Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytochrome P450 3A4 also known as CYP3A4 is an enzyme that plays an important role in the metabolism of many xenobiotics and endogenous compounds. It belongs to the cytochrome P450 superfamily and is a monooxygenase with a mass of approximately 57 kDa. CYP3A4 is primarily expressed in the liver and small intestine although it can be found in other tissues at lower levels. This enzyme catalyzes the oxidation of a wide variety of structurally unrelated compounds facilitating their excretion. Proadifen is a known inhibitor of CYP3A4 often used in research to study the effects of enzyme inhibition.
Biological function summary

CYP3A4 is involved in the metabolism of approximately half of all drugs used in clinical settings making it one of the most significant enzymes in drug metabolism. It does not usually function as part of a larger complex but acts individually on various substrates. Besides xenobiotic metabolism CYP3A4 also metabolizes steroids and other endogenous molecules. Climbazole an antifungal agent is a substrate for CYP3A4 demonstrating the enzyme's broad substrate specificity within the body's complex biochemical environment.

Pathways

CYP3A4 plays a central role in the drug metabolism pathway and the synthesis and metabolism of steroids. These pathways involve other cytochrome P450 enzymes including CYP2D6 and CYP2C9 which often work alongside CYP3A4 to metabolize compounds. The pathway's coordinated activities ensure proper drug metabolism and hormone regulation. Understanding the involvement of CYP3A4 in these pathways is critical for drug development and determining drug-drug interactions.

CYP3A4 is associated with conditions such as drug-induced liver injury and variable drug responses. Alterations in CYP3A4 activity can lead to either toxic accumulations or reduced efficacy of medications. Additionally certain liver diseases can alter CYP3A4 expression further complicating treatment outcomes. The enzyme's interaction with other proteins like those of the cytochrome P450 family means that any dysfunctions can impact a wide range of metabolic processes and influence disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed : 10681376, PubMed : 11093772, PubMed : 11555828, PubMed : 12865317, PubMed : 14559847, PubMed : 15373842, PubMed : 15764715, PubMed : 19965576, PubMed : 20702771, PubMed : 21490593, PubMed : 21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed : 12865317, PubMed : 14559847, PubMed : 15373842, PubMed : 15764715, PubMed : 21490593, PubMed : 21576599, PubMed : 2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed : 11555828, PubMed : 12865317, PubMed : 14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed : 15373842, PubMed : 15764715, PubMed : 22773874, PubMed : 2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed : 15373842, PubMed : 15764715, PubMed : 2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed : 21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed : 9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed : 19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed : 20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed : 10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed : 11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed : 11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed : 10759686). Hydroxylates antimalarial drug quinine (PubMed : 8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed : 11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed : 29461981).
See full target information CYP3A4

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Organogenesis 18:2061263 PubMed35435152

2022

Hepatocyte Differentiation from iPSCs or MSCs in Decellularized Liver Scaffold: Cell-ECM Adhesion, Spatial Distribution, and Hepatocyte Maturation Profile.

Applications

Unspecified application

Species

Unspecified reactive species

Radiana Dhewayani Antarianto,Adrian Pragiwaksana,Wahyunia Likhayati Septiana,Nuzli Fahdia Mazfufah,Ameer Mahmood

Translational andrology and urology 10:4275-4287 PubMed34984192

2022

Inflammation induced by lipopolysaccharide advanced androgen receptor expression and epithelial-mesenchymal transition progress in prostatitis and prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Guang-Chun Wang,Tian-Run Huang,Ke-Yi Wang,Zong-Lin Wu,Jin-Bo Xie,Hou-Liang Zhang,Lei Yin,Wen-Long Tang,Bo Peng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com